Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Trends in Biotechnology|February 1, 1997
Hepatitis C virus diagnostics: technology, clinical applications and impactsC Conry-CantilenaTransfusion|June 16, 2001
MCV as a guide to phlebotomy therapy for hemochromatosisC D Bolan, C Conry-Cantilena, G Mason, et al.The American Journal of Clinical Nutrition|May 1, 1997
Use of a new vitamin C-deficient diet in a depletion/repletion clinical trialJ King, Y Wang, R W Welch, et al.Pharmaceutical Research|November 5, 1997
Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletionJ F Graumlich, T M Ludden, C Conry-Cantilena, et al.Hepatology (Baltimore, Md.)|September 26, 1997
Hepatitis C in asymptomatic blood donorsH J Alter, C Conry-Cantilena, J Melpolder, et al.Journal of Viral Hepatitis|July 17, 2001
Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriersA E Yeo, M Ghany, C Conry-Cantilena, et al.The New England Journal of Medicine|June 27, 1996
Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infectionC Conry-Cantilena, M VanRaden, J Gibble, et al.The Journal of Infectious Diseases|April 7, 1999
Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virusD Tan, A Matsumoto, C Conry-Cantilena, et al.Annals of Internal Medicine|September 1, 1995
Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study GroupA O Shakil, C Conry-Cantilena, H J Alter, et al.Proceedings of the National Academy of Sciences of the United States of America|April 16, 1996
Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowanceM Levine, C Conry-Cantilena, Y Wang, et al.Pageof 1